Mycronic AB (MYCR) Fair Value & Analysis
Industrials · SE · Market cap 57.9B SEK
Fair value as of: Aug 13, 2026
From 26 valuation models · updated today
Share price −1.6% over the past month.
Below-average quality, and screening another 43% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (kr 234.84). The favourable scenario is already priced in.
- Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (kr 118.68 to kr 234.84) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range kr 57.30 – kr 350.40 · fair‑value band kr 118.68 – kr 234.84 · the kr 333.80 price screens above the kr 189.59 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Mycronic AB (MYCR) currently trades at kr 333.80, while our model-based Fair Value estimate is kr 189.59, implying the stock looks roughly 43.2% overvalued today. The Quality Score stands at 49/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Mycronic AB generated revenue of 8.3B SEK at a net margin of 19.9%. Revenue grew 16.9% year over year. It earns a return on equity of 22.2%. The balance sheet holds a net cash position of 2.0B SEK. Fundamentals as of Aug 13, 2026
Our scenario range runs from kr 118.68 (bear case) to kr 234.84 (bull case); at kr 333.80, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 94% above its 52-week low, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -46% fair-value upside, at -43%, MYCR screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (kr 202.66) versus Asset-Based (kr 24.39). Highest evidence: Growth DCF (80).
Notify me when MYCR reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 51 · Market factors (momentum, volatility) 84
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. It operates through four segments: Pattern Generators, PCB Assembly, High-Volume, and Global Technologies.
Full company description
Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. It operates through four segments: Pattern Generators, PCB Assembly, High-Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and metrology systems for display manufacturing and production of semiconductors. The PCB Assembly segment develops, manufactures, and markets flexible PCB assembly solutions, including jet printing, stencil printing, 3D inspection, component placement, and automated storage solutions. The High-Volume segment develops, manufactures, and markets automated system for dispensing and conformal coating for high-volume electronics production. The Global Technologies segment offers die bonding, PCB test, photonic interconnects, magnetic test, and applied plasma. The company sells its products through agents and distributors. It serves aerospace, defense, medical, and industrial electronics sectors. The company was formerly known as Micronic Mydata AB (publ) and changed its name to Mycronic AB (publ) in June 2014. Mycronic AB (publ) was incorporated in 1989 and is headquartered in Täby, Sweden.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Mycronic AB reported revenue of kr 7.9B in FY2025 versus kr 4.6B in FY2021, a compound +14.4%/yr. Reported net income was kr 1.6B in FY2025, compounding +17.2%/yr from FY2021.
of which total revenue +15.6 pp · buybacks/dilution −3.6 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
MYCR screens 43% overvalued. Compare with GE Vernova Inc →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Mycronic AB (MICLF) Q2 2026 Earnings Call Highlights: Record Order Intake and Strong Margins ...
- Mycronic (OM:MYCR) Stock After 52% One-Year Gain Is The Current Price Justified
- Mycronic AB (FRA:MLT0) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
- Mycronic AB (FRA:MLT0) Q3 2025 Earnings Call Highlights: Strong Order Intake Amid Sales Decline
Peer Group
Specialty Industrial Machinery · 807 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Industrial Machinery median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| GE Vernova Inc 1GEV | €899.80 | €186.93 | -79% |
| 1SIE 1SIE | €281.75 | €91.93 | -67% |
| SMNS SMNS | C$31.76 | C$22.75 | -28% |
| Atlas Copco AB ATCOA | kr 210.00 | kr 112.59 | -46% |
| Sandvik AB SAND | kr 358.60 | kr 193.01 | -46% |
| Zhejiang Sanhua Intelligent Controls Co 002050 | ¥39.17 | ¥22.68 | -42% |
| NARI Technology Co 600406 | ¥24.06 | ¥18.71 | -22% |
| ABB India Limited ABB | ₹7,700 | ₹1,322 | -83% |
| Cummins India Limited CUMMINSIND | ₹5,315 | ₹1,355 | -75% |
| Bharat Heavy Electricals Limited BHEL | ₹420.00 | ₹96.51 | -77% |
Compare Mycronic AB with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Mycronic AB (MYCR) overvalued or undervalued?
What is the fair value of MYCR?
What is the quality score of MYCR?
What is the revenue of Mycronic AB (MYCR)?
What is the net profit margin of MYCR?
Does Mycronic AB pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Mycronic AB and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.